All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
October 2024: New CGM devices added
News
October 2024: New CGM devices added
The following devices have been added to the formulary:
Dexcom ONE+ continuous glucose monitor for use in diabetes
- This device replaces Dexcom ONE which is due to be discontinued in May 2025.
- Information is available in the formulary entry to help guide the transition of patients from Dexcom ONE to Decom ONE+.
- Dexcom ONE+ sensors now have an integrated transmitter meaning that this item does not need to be prescribed separately.
- See here for the formulary entry.
FreeStyle Libre 2 Plus continuous glucose monitor for use in diabetes
- This device replaces FreeStyle Libre 2 which is due to be discontinued in June 2025.
- Information is available in the formulary entry to help guide the transition of patients from FreeStyle Libre 2 to FreeStyle Libre 2 Plus.
- FreeStyle Libre 2 Plus sensors require replacement every 15 days.
- See here for the formulary entry.
FreeStyle Libre 3 continuous glucose monitor for use in diabetes
- This system is only recommended when used as part of a hybrid closed loop system in pregnancy in line with NICE TA943.
- Not recommended as a standalone CGM.
- See here for the formulary entry.
Continuous glucose monitors are listed as amber items in the formulary meaning that they are usually initiated by specialist diabetes teams; however, initiation by primary care health professionals who are confident to do this without specialist input is accepted.
